Monday, 24 January 2022

Dietary Supplements Market Value Surpass USD 279.2 Billion by 2030

The global Dietary Supplements Market size is estimated to generate revenues of more than USD 279.2 billion by 2030, growing at a CAGR of around 8.4% from 2021 to 2030

Dietary Supplements


The report covers SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. The report offers an analysis of the global dietary supplements Market for the period 2016 to 2030, wherein 2021 to 2030 is the forecast period and 2020 is considered as the base year.

The wide application portfolio of dietary supplements market is one of factors driving the growth of market worldwide. The global market is moderately competitive with a blend of global and regional players. The markets key players invest significantly in R and D to enhance their offerings. The entire ecosystem is composed of multiple participants. Every participant of the ecosystem is an equal contributor to the growth of global market.

Why should you invest in this report?

If you are aiming to enter the global dietary supplements Market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for dietary supplements are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly. Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Report Structure:

  • pertinent market numbers of the global dietary supplements market along with the CAGR for the forecast period 2021-2030
  • detailed definitions of different types of dietary supplements, which gives clarity about what this market is all about and also defines the scope of this report
  • macroeconomic factors influencing the global dietary supplements market, along with market opportunity analysis
  • key trends likely to impact the global dietary supplements market
  • PESTLE analysis of all the regions as per the market taxonomy
  • Porter’s Five Force Analysis of all the regions as given in the market taxonomy

Global market analysis and forecast:

  • the global dietary supplements market analysis and forecast by product type, by application, by region and others
  • key market metrics such as the BPS analysis, year-on-year growth rates, absolute dollar opportunity and market attractiveness analysis of the global dietary supplements market

Regional market analysis and forecast:

  • Regional dietary supplements market analysis and forecast
  • Regional market dynamics including the drivers, restraints and trends applicable across different regions in the dietary supplements market along with factors encouraging the growth of this market as well as the factors hampering the growth of this market
  • Regional trends – both long term and short term

View Full Report@ https://www.precedenceresearch.com/dietary-supplements-market

Competitive landscape:

  • the competitive landscape of this global report
  • information on the various leading companies in the global market
  • a dashboard view of the key companies operating in the global market along with their important information and broad strategy adopted to stay as leaders in the global market
  • key company profiles along with important information such as company details, company description, product portfolio along with key developments concerning the company and strategic analysis

Some of the prominent players in dietary supplements market include:

  • Bayer
  • NBTY Inc
  • Bionova Lifesciences
  • Nu Skin Enterprises
  • Carlyle Group
  • Pfizer
  • Arkopharma Laboratoires Pharmaceutiques
  • Glanbia
  • Herbalife International
  • Abbott Laboratories
  • GlaxoSmithKline
  • Nature’s Sunshine Forms
  • Amway
  • Archer Daniels Midland

Market Segmentation:

By Type

  • Vitamins
  • Minerals
  • Fibers & Specialty Carbohydrates
  • Omega Fatty Acids
  • Botanicals
  • Proteins & Amino Acids
  • Others

By Form

  • Capsules
  • Tablets
  • Gummies
  • Soft gels
  • Liquids
  • Powders
  • Others

By Application

  • General Health
  • Energy & Weight Management
  • Gastrointestinal Health
  • Diabetes
  • Bone & Joint Health
  • Immunity
  • Cardiac Health
  • Anti-cancer
  • Others

By End User

  • Geriatric
  • Adults
  • Children
  • Infants

By Geography

  • North America

·          

o     

      • U.S.
      • Canada
  • Europe

o     

      • Germany
      • France
      • United Kingdom
      • Rest of Europe
  • Asia Pacific

o     

      • China
      • Japan
      • India
      • Southeast Asia
      • Rest of Asia Pacific
  • Latin America

o     

      • Brazil
      • Rest of Latin America
  • Middle East & Africa (MEA)

o     

      • GCC
      • North Africa
      • South Africa
      • Rest of Middle East & Africa

Research Methodology

In this report, historical data, primary responses and public domain data has been thoroughly analyzed to infer the market size. Revenue of companies operating in the global market has been benchmarked to ascertain the market size for the base year. Macroeconomic indicators such as GDP and industry growth have been considered to determine the market size for the forecast period. The historical growth trend of end-use industries, market participants’ performance, as well as the present macro-economic outlook has been taken into consideration for estimating the overall market trend forecast. This data is then validated using the triangulation method and extensively scrutinized using advanced tools to garner quantitative and qualitative insights into the global dietary supplements.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Dietary Supplements Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Dietary Supplements Market

5.1. Covid-19: Dietary Supplements Industry Impact
5.2. Dietary Supplements Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Dietary Supplements Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Dietary Supplements Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Dietary Supplements Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Rising health concerns and the changing lifestyles
6.1.1.2. Growth in the number of sports complexes and gymnasiums
6.1.2. Market Restraints
6.1.2.1. Rising demand for organic food
6.1.3. Market Opportunities
6.1.3.1. Emerging applications

Chapter 7. Global Dietary Supplements Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Dietary Supplements Market Revenue by Market Players (2017 - 2020)
7.1.1.2. Dietary Supplements Market Revenue Market Share by Market Players (2017 - 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Dietary Supplements Market, By Type

8.1. Dietary Supplements Market, by Type, 2017-2030
8.1.1. Vitamins
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Minerals
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Fibers & Specialty Carbohydrates
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Omega Fatty Acids Botanicals
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Proteins & Amino Acids
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Dietary Supplements Market, By Applications

9.1. Dietary Supplements Market, by Applications, 2017-2030
9.1.1. General Health
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Energy & Weight Management
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Gastrointestinal Health
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Diabetes
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Bone & Joint Health
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Immunity
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Cardiac Health
9.1.7.1. Market Revenue and Forecast (2017-2030)
9.1.8. Anti-cancer
9.1.8.1. Market Revenue and Forecast (2017-2030)
9.1.9. Others
9.1.9.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Dietary Supplements Market, By Form

10.1. Dietary Supplements Market, by Form, 2017-2030
10.1.1. Capsules
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Tablets
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Gummies
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Soft gels
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Liquids
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Powders
10.1.6.1. Market Revenue and Forecast (2017-2030)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Dietary Supplements Market, By End user

11.1. Dietary Supplements Market, by End user, 2017-2030
11.1.1. Geriatric
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Adults
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Children
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Infants
11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Dietary Supplements Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Type(2017-2030)
12.1.2. Market Revenue Forecast by Application (2017-2030)
12.1.3. Market Revenue Forecast by Form (2017-2030)
12.1.4. Market Revenue Forecast by End user (2017-2030)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2017-2030)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2017-2030)
12.2. Europe
12.2.1. Market Revenue Forecast by Type (2017-2030)
12.2.2. Market Revenue Forecast by Application (2017-2030)
12.2.3. Market Revenue Forecast by Form (2017-2030)
12.2.4. Market Revenue Forecast by End user (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2017-2030)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2017-2030)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Type (2017-2030)
12.3.2. Market Revenue Forecast by Application (2017-2030)
12.3.3. Market Revenue Forecast by Form (2017-2030)
12.3.4. Market Revenue Forecast by End user (2017-2030)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2017-2030)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2017-2030)
12.4. LATAM
12.4.1. Market Revenue Forecast by Type (2017-2030)
12.4.2. Market Revenue Forecast by Application (2017-2030)
12.4.3. Market Revenue Forecast by Form (2017-2030)
12.4.4. Market Revenue Forecast by End user (2017-2030)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2017-2030)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2017-2030)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Type (2017-2030)
12.5.2. Market Revenue Forecast by Application (2017-2030)
12.5.3. Market Revenue Forecast by Form (2017-2030)
12.5.4. Market Revenue Forecast by End user (2017-2030)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2017-2030)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2017-2030)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2017-2030)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2017-2030)

Chapter 13. Company Profiles

13.1. Bayer
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2017-2020)
13.1.4. Recent Developments and Strategies
13.2. NBTY Inc
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2017-2020)
13.2.4. Recent Developments and Strategies
13.3. Bionova Lifesciences
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2017-2020)
13.3.4. Recent Developments and Strategies
13.4. Nu Skin Enterprises
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2017-2020)
13.4.4. Recent Developments and Strategies
13.5. Carlyle Group
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2017-2020)
13.5.4. Recent Developments and Strategies
13.6. Pfizer
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2017-2020)
13.6.4. Recent Developments and Strategies
13.7. Arkopharma Laboratoires Pharmaceutiques
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2017-2020)
13.7.4. Recent Developments and Strategies
13.8. Glanbia
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2017-2020)
13.8.4. Recent Developments and Strategies
13.9. Herbalife International
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2017-2020)
13.9.4. Recent Developments and Strategies
13.10. Abbott Laboratories
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2017-2020)
13.10.4. Recent Developments and Strategies
13.11. GlaxoSmithKline
13.11.1. Company Overview, Business Information, Regional Presence
13.11.2. Product Portfolio Analysis
13.11.2.1. Product Details, Specification, Application
13.11.3. Revenue, Price, and Gross Margin (2017-2020)
13.11.4. Recent Developments and Strategies
13.12. Nature’s Sunshine Forms
13.12.1. Company Overview, Business Information, Regional Presence
13.12.2. Product Portfolio Analysis
13.12.2.1. Product Details, Specification, Application
13.12.3. Revenue, Price, and Gross Margin (2017-2020)
13.12.4. Recent Developments and Strategies
13.13. Amway
13.13.1. Company Overview, Business Information, Regional Presence
13.13.2. Product Portfolio Analysis
13.13.2.1. Product Details, Specification, Application
13.13.3. Revenue, Price, and Gross Margin (2017-2020)
13.13.4. Recent Developments and Strategies
13.14. Archer Daniels Midland
13.14.1. Company Overview, Business Information, Regional Presence
13.14.2. Product Portfolio Analysis
13.14.2.1. Product Details, Specification, Application
13.14.3. Revenue, Price, and Gross Margin (2017-2020)
13.14.4. Recent Developments and Strategies

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms
   

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333      

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Blog: http://www.marketstatsnews.com/

Follow us on LinkedIn | Twitter | Facebook

Share:

0 comments:

Post a Comment